SPONSOR
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Total Trials
6
Recruiting
6
Phases
Phase 4
Conditions studied: Premature Ventricular ComplexesAdvanced Colorectal CarcinomaRheumatoid Arthritis (RAOsteoporosisOsteoarthritisInterstitial Lung DiseaseThyroid DiseasesCardiovascular DiseasesPulmonary ComplicationsSjogren's Syndrome
Guang'anmen Hospital of China Academy of Chinese Medical Sciences is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Premature Ventricular Complexes, Advanced Colorectal Carcinoma, Rheumatoid Arthritis (RA, Osteoporosis.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Guang'anmen Hospital of China Academy of Chinese Medical Sciences
How many clinical trials has Guang'anmen Hospital of China Academy of Chinese Medical Sciences sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Guang'anmen Hospital of China Academy of Chinese Medical Sciences, of which 6 are actively recruiting participants. These trials cover conditions including Premature Ventricular Complexes, Advanced Colorectal Carcinoma, Rheumatoid Arthritis (RA. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Guang'anmen Hospital of China Academy of Chinese Medical Sciences research focus on?
Guang'anmen Hospital of China Academy of Chinese Medical Sciences clinical trials span Premature Ventricular Complexes, Advanced Colorectal Carcinoma, Rheumatoid Arthritis (RA, Osteoporosis, Osteoarthritis, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Guang'anmen Hospital of China Academy of Chinese Medical Sciences clinical trial?
To participate in a Guang'anmen Hospital of China Academy of Chinese Medical Sciences trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Guang'anmen Hospital of China Academy of Chinese Medical Sciences trials with current recruitment status updated daily.
Clinical Trials by Guang'anmen Hospital of China Academy of Chinese Medical Sciences
NCT04415203
Recruiting
TAES for FPVCs: a Pragmatic, Randomized Controlled Trial
Premature Ventricular Complexes
NCT05894694 Phase 4
Recruiting
Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer
Advanced Colorectal Carcinoma
NCT07301892
Recruiting
Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
Rheumatoid Arthritis (RA
NCT06284993
Recruiting
Acupuncture of Different Treatment Frequency in Chronic Plantar Fasciitis
Plantar Fasciitis, Chronic
NCT06410430
Recruiting
Exploration the Mechanism of Ba-Duan-Jin in the Treatment of Fibromyalgia Based on Brain-gut Axis
Fibromyalgia
NCT04815668
Recruiting
Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis
Seasonal Allergic Rhinitis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology